Difference between revisions of "Orazio Satta"

From WOI Encyclopedia Italia
Jump to navigation Jump to search
m
 
m
Line 6: Line 6:
 
He studied [[mechanical engineering]] (1933) and [[aeronautics|aeuronautical engineering]] (1935) at the [[Politecnico di Torino]]  and joined the design department of [[Alfa Romeo]] ([[March 2]], [[1938]]), working under the direction of [[Wifredo Ricart]].  Satta followed Ricart as head of design (1946), overseeing the  [[Alfa Romeo 158/159 Alfetta|158 and 159]], [[Alfa Romeo 1900]], [[Alfa Romeo Giulietta]], [[Alfa Romeo Giulia]], [[Alfa Romeo Montreal]] and [[Alfa Romeo Alfetta]].   
 
He studied [[mechanical engineering]] (1933) and [[aeronautics|aeuronautical engineering]] (1935) at the [[Politecnico di Torino]]  and joined the design department of [[Alfa Romeo]] ([[March 2]], [[1938]]), working under the direction of [[Wifredo Ricart]].  Satta followed Ricart as head of design (1946), overseeing the  [[Alfa Romeo 158/159 Alfetta|158 and 159]], [[Alfa Romeo 1900]], [[Alfa Romeo Giulietta]], [[Alfa Romeo Giulia]], [[Alfa Romeo Montreal]] and [[Alfa Romeo Alfetta]].   
 
He later became central director (1951) and finally general vice president (1969-73), before retiring due to Brain Cancer.
 
He later became central director (1951) and finally general vice president (1969-73), before retiring due to Brain Cancer.
 +
  
  

Revision as of 16:57, 2 February 2009


Orazio Satta Puliga (October 6, 1910 in Torino - 1974) was an Italian automobile designer known from several Alfa Romeo designs.

He studied mechanical engineering (1933) and aeuronautical engineering (1935) at the Politecnico di Torino and joined the design department of Alfa Romeo (March 2, 1938), working under the direction of Wifredo Ricart. Satta followed Ricart as head of design (1946), overseeing the 158 and 159, Alfa Romeo 1900, Alfa Romeo Giulietta, Alfa Romeo Giulia, Alfa Romeo Montreal and Alfa Romeo Alfetta. He later became central director (1951) and finally general vice president (1969-73), before retiring due to Brain Cancer.